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The modern concept of neurogenesis in the adult brain is predi-
cated on the premise that multipotent glial cells give rise to new
neurons throughout life. Although extensive evidence exists indi-
cating that this is the case, the transition from glial to neuronal
phenotype remains poorly understood. A unique monolayer cell-
culture system was developed to induce, expose, and recapitulate
the entire developmental series of events of subventricular zone
(SVZ) neurogenesis. We show here, using immunophentoypic,
ultrastructural, electrophysiological, and time-lapse analyses, that
SVZ-derived glial fibrillary acidic proteinlowA2B5nestin candi-
date founder cells undergo metamorphosis to eventually generate
large numbers of fully differentiated interneuron phenotypes. A
model of postnatal neurogenesis is considered in light of known
embryonic events and reveals a limited developmental potential of
SVZ stemprogenitor cells, whereby ancestral cells in both embry-
onic and postnataladult settings give rise to glia and GABAergic
interneurons.
adult stem cells  electrophysiology  in vitro  neurogenesis 
subventricular zone
A ttempts to trace the cellular source of neurogenesis in the adultCNS have recently led to the surprising conclusion that
dedicated glial cells give rise to new neurons throughout life (1–5).
Even though neurons and glia are both derived from the embryonic
neuroepithelium, sharing common signaling pathways and down-
stream transcription factors during development (6), it is difficult to
imagine how one major cell class in the adult brain can transpose
into the other. Postnatal neurogenesis in the subventricular zone
(SVZ) of rodents proceeds as a characteristic series of events, where
multipotent glial cells (referred to as type-B cells) can divide to form
colonies of neuroblasts (type-A cells) through a transit-amplifying
cell population (type-C cells) (7). Newborn neuroblasts migrate
from the SVZ through the rostral migratory stream and mature to
GABAergic granule cells and periglomerular cells, which, 3–4
weeks after generation, integrate as inhibitory interneurons into the
olfactory bulb of rodents (8–10). Certain features, such as nestin-
and glial-fibrillary acidic protein (GFAP) expression, are ascribed
to the founder cells of postnatal neurogenesis (3, 11–14), but their
distinctive antigenic and functional profiles remain elusive. Tradi-
tional approaches for the isolation and characterization of persis-
tent neurogenesis have relied on the in vitro neurosphere (NS) assay
(15, 16) or on post hoc identification, depending on the incorpo-
ration of BrdUrd andor retroviral constructs to label precursors
during cell division. However, neither of these methods affords the
recognition of the dynamic processes involved in the maturation of
individual cells en route from stem cells to fully differentiated
neural phenotypes.
Here, we present an alternative culture model that closely
recapitulates in vivo postnataladult SVZ neurogenesis, allowing us
tomonitor the entire sequence of hierarchical events from glial-like
stem cells to functionally mature (inter)neurons, and to expose the
phenotypical and electrophysiological properties of cells in transit.
Materials and Methods
Tissue Culture. SVZ cells from postnatal day 8 (P8) and adult
(90-d-old) animals (C57B6mice, The Jackson Laboratory) were
placed in DMEMF-12 (DF) containing 100 unitsml penicillin,
100 gml streptomycin, and 250 ngml amphotericin B (collec-
tively, abx), as described in ref. 3. Extracted tissues of five animals
were pooled and triturated in 0.005% trypsin (15min, 37°C, pH 7.3)
and placed overnight in uncoated T75 plastic tissue-culture dishes
in N5 medium [DF containing N2 supplements, 35 gml bovine
pituitary extract, abx, 5% FCS (HyClone), and 40 ngml EGF and
basic FGF]. Unattached cells were collected, gently triturated by
using fire-polished pipettes, replated onto uncoated plastic dishes,
and proliferated to confluency in N5 media. EGF and FGF (20 ng
each)were added every other day. Confluent cell layers were frozen
in aliquots of 1  106 cells and maintained in liquid nitrogen. For
experimentation, cells were thawed andpassaged twoormore times
by using 0.005% trypsin and N5 media, with 20 ng/ml EGFFGF
supplementation every other day. To induce differentiation, the
cells were plated on glass coverslips coated with 10 gml polyor-
nithine (Sigma) and 1 gml laminin (LPO) at densities of 2 
105 cells per cm2. The cells were proliferated to 90–100% conflu-
ency and were induced to differentiate by removing growth factors
and serum from the culture media. Dividing cells were labeled with
10 M BrdUrd (Sigma). Functional neurons were generated by a
protocol adapted from Song et al. (17). Briefly, retinoic acid (0.5
M, Sigma) was added between 7 and 10 d after the induction of
differentiation and replaced every other day for a period of 6 d.
Cytosine -D-arabinofuranoside (0.5M, Sigma) was added for 2 d
after the retinoic acid treatment. Neurons were allowed to differ-
entiate in N2-supplemented DF with 0.5% FCS and 20 ngml
brain-derived neurotrophic factor. The media were changed every
other day. Unless otherwise specified, media and growth factors
were obtained from Invitrogen and R & D Systems, respectively.
Nestin–GFP-expressing animals (18) (age- and sex-matched to
C57B6 mice) were decapitated, and their brains were placed
overnight in ice-cold DF containing abx and processed identically.
All procedures were approved and performed in accordance with
University of Florida Institutional Animal Care and Use Commit-
tee guidelines.
Neurosphere Assay. Passage-5 cells from P8 and adult SVZ were
trypsinized, counted, and resuspended in nonadhesive six-well
plates (Corning) in 2-ml-per-well N5 media containing 1% meth-
ylcellulose, as described in refs. 3 and 16. To verify the clonality of
NS generated under these conditions, serial dilution of SVZ cells
was performed from 0.6 to 20  103 cells per cm2. A linear
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seedingNS relationship was observed at densities between 2.5 and
20  103 cells per cm2 (data not shown). All NS experiments were
performed at a seeding density of 104 cells per cm2. To quantify the
presence of sphere-forming cells, the total numbers of primary NS
were counted per well by using bright-field microscopy (n 3 each
for adult and P8 cultures, derived from two independent experi-
ments). Secondary NS were derived from dissociated primary NS
and evaluated similarly (n 2 each for adult and P8 cultures, from
two independent experiments). NS were evaluated at 14–21 d after
cell-seeding. The level of statistical significance was set at P 0.01
and was calculated by using Student’s t test. NS were plated on
LPO-coated glass coverslips overnight inN5media. Cells migrating
out of NS were allowed to differentiate for 7 d after removing
growth factors and serum from the culture media. Individual
primary and secondary NS were assessed for multipotentiality by
double-immunofluorescence analysis with neuronal (III tubulin,
MAP 2, and NeuN) and glial (CNPase, GFAP, and O4) marker
proteins.
Live Cell Microscopy. Passage-3 SVZ cells were grown to confluency
in N5 media on LPO-coated 3-cm glass coverslip dishes (WillCo
Wells, Amsterdam). The cells were induced to differentiate, as
described above, and were monitored under standard culture
conditions (37°C, 5% humidified CO2) on a Zeiss Cell Observer
system. Five randomized visual fields (200) were selected for
analysis 24 h after the induction of differentiation. Phase images
were taken every 5 min for up to 30 h. Images were compiled into
movies by using the program AXIOVISION (Zeiss).
Electrophysiology. The cells were placed in a holding chamber
continuously perfusedwith oxygenated artificial cerebrospinal fluid
containing 125 mM NaCl, 3 mM KCl, 26 mM NaHCO3, 1.25 mM
NaH2PO4, 20 mM glucose, 1 mM MgCl2, and 2 mM CaCl2 and
maintained at 35°C during the experiments. The intracellular
pipette solution consisted of 145 mM potassium gluconate, 10 mM
Hepes, 10mMEGTA, and 5mMMgATP (pH7.2, osmolarity 290).
For experiments in which postsynaptic currents were recorded, 145
mM potassium gluconate was replaced with 125 mM KCl and 20
mM potassium gluconate. Recordings were performed with an
Axopatch-1D tight-seal patch clamp (Axon Instruments, Union
City, CA) and filtered at 5 kHz. The program CLAMPEX 8.2 (Axon
Instruments) was used to deliver command potentials and for data
collection. Series resistances were 20 M and were checked
frequently to ensure that they did not deviate. For voltage-clamp
experiments, a step protocol was applied that held the membrane
at potentials between 80 mV and 60 mV for 50 ms after a
prepulse period of 200 ms at 100 mV. During current-clamp
experiments, a step protocol was used in which currents between 10
and 100 pAper stepwere applied. The programCLAMPFIT 8.2 (Axon
Instruments) was used to analyze voltage and current traces.
Picrotoxinwas applied at 50M, tetraethylammoniumchloridewas
applied at 20 mM, and tetrodotoxin was applied at 400 nM
(Alomone Labs, Jerusalem). Chemicals and reagents were ob-
Fig. 1. Monolayers of SVZ cells can be induc-
ibly differentiated into newborn neuroblasts.
(a) Phase-contrast appearance of a proliferat-
ing passage-5 SVZ culture. (b) Three-dimen-
sional reconstruction. Large GFAP cells overlie
compact nestin-expressing cells. (c and d) Elec-
tron micrographs show cells with astrotypic
morphology, containing abundant intermedi-
ate filaments. (e) Low levels of GFAP are found
in a subpopulation of underlying nestin (im-
age not shown)A2B5 cells. The arrow points
to a GFAPlowA2B5 cell. (Inset) One of these
cells undergoing division. ( f) Proliferating SVZ
cultures contain 57.3	 4.3% GFAP and 42.3	
1.5% A2B5 cells. With induced differentia-
tion, GFAP expression among A2B5 cells
(26.6 	 6.3% during proliferation) decreases
sequentially to 15.7 	 1.5% and 2.9 	 1.5% at
1 and 4 d after growth-factor withdrawal, re-
spectively. (gandh) At 24 h after growth-factor
removal, differentiating cells display heteroge-
neous nuclear compaction and transiently co-
express A2B5 and III tubulin. (h Inset) Mitotic
cell identified by asterisk in g. (i) These mitotic
cells maintain an intermediate morphology, in-
cluding cell size and nuclear diameter and dis-
play extremely abundant mitochondria and
free ribosomes (j). (k) Defined neuroblasts be-
come abundant 4 d after the initiation of dif-
ferentiation and are revealed by compacted
nuclei and phase-dark morphology (Inset). (l)
Cells are PSA-NCAM and weakly Dlx-2 and
are ultrastructurally similar to mixtures of types
A and C cells in the SVZ (m). [Scale bars (in m):
a, 200; b, 50; e, h, and l, 30; c, 10; i and m, 5; d
and j, 2.]
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tained from Sigma unless otherwise noted. Data are expressed as
mean 	 SEM.
Immunocytochemistry. Cells were fixed and processed for immuno-
cytochemistry, as described in ref. 3. Monoclonal antibodies in-
cluded A2B5 (1:300; Chemicon), III tubulin (1:3,000; Promega),
BrdUrd (1:50; Becton Dickinson), 2
,3
 cyclic nucleotide 3
-
phosphohydrolase (CNPase) (1:250; Chemicon), NeuN (1:50;
Chemicon), O4 (1:150; Chemicon), and polysialylated neural cell
adhesion molecule (PSA-NCAM) (1:400; Chemicon) and poly-
clonal antibodies Map-2 (1:30,000; a gift from Gerry Shaw, Uni-
versity of Florida), Dlx-2 (1:50; Santa Cruz Biotechnology), glu-
tamic acid decarboxylase (GAD) 6567 (1:125; Chemicon), and
GFAP (1:600; DAKO), and were detected by using appropriate
secondary antibodies (Molecular Probes and The Jackson Labo-
ratory). Secondary antibodies were applied for 45 min at room
temperature in PBS, including 0.1% Triton and 10% FCS. Nuclei
were visualized by using a 1 gml DAPI stain (Sigma). Fluores-
cence microscopy was performed and captured on a Leica DMLB
upright microscope. Three-dimensional imaging on some speci-
mens was performed by using a fully automated Axiovert 200
inverted microscope equipped with Apotome technology, and
images were reconstructed by using the program AXIOVISION
(Zeiss).
Electron Microscopy. Passage-3 SVZ cells were grown in N5 media
onLPO-coatedAclar coverslips. Fixation and processingwere done
according to standard protocols. Samples were visualized on a
Leica EM10A transmission electron microscope at magnifications
between 1 and 16,000. Images were captured by using a
charge-coupled device digital camera (Finger Lakes Instrumenta-
tion, Lima, NY).
Results
To expand a putative SVZ stem-cell population and to remove cells
of limited proliferative capacity, single-cell suspensions of micro-
dissected SVZ tissue were proliferated as adherent monolayers for
5 population doublings (at least three passages) in 5% serum-
containingmedia supplementedwithEGFandFGF (Fig. 1a). Cells
expressing mature neuronal (NeuN andMap2) or oligodendrocyte
(CNPase and O4) markers were not detected in expanded prolif-
erating cultures. Instead, a mixture of mature astrocytes expressing
GFAP and immature nestin glial phenotypes was present (Fig.
1b). The ultrastructural analysis of proliferating cells exposed
abundant protoplasmic astrotypemorphologies with extensive bun-
dled intermediate filaments (Fig. 1 c and d). SVZmonolayers could
be proliferated for 75 population doublings without senescence
and, when transferred to nonadhesive conditions, multipotent
primary and secondary neurospheres formed at passage 5 (3.2 	
0.06% and 0.83 	 0.25%, respectively) and at passage 25 (4.12 	
0.79% and 0.81 	 0.13%) (data not shown). These observations
indicate the maintenance of multipotent self-renewing cells in
adherent conditions. Further examination of proliferating SVZ
cultures revealed a nestinA2B5 population of cells, among
which 26.6 	 6.3% coexpressed low levels of GFAP. These cells
showed compact morphologies and, frequently, signs of mitotic
activity (Fig. 1 e and e Inset). The removal of growth factors and
serum induced simultaneous differentiation of proliferating cul-
tures and reduced the number of A2B5GFAPlow-expressing cells
sequentially (Fig. 1f). At the same time, the rapid generation of
committed neuronal progeny was observed. At 24 h, glial cells
expressing A2B5 and nestin (data not shown) transiently coexpress
III tubulin (Fig. 1 g and h), a polycomb gene family member
expressed during neuronal fate choice (19, 20). These morpholog-
ically unique cells are devoid of GFAP (data not shown) and
contain large quantities ofmitochondria and ribosomes (Fig. 1 i and
j). Compacted cell colonies appear 3–4 d after growth-factor
withdrawal. Individual cells were small and round and ubiquitously
expressed III tubulin, nestin, and A2B5 (data not shown) as well
as PSA-NCAM and low, weak levels of Dlx2 (Fig. 1 k and l).
Phenotypic and ultrastructural hallmarks correspond tomixtures of
A and C cells described in vivo (21) (Fig. 1m). This phenomenon
was specific to cultures from the SVZ; characteristic A and C cells
could not be derived from cell dissociations of identically prepared
parietal neocortex. To evaluate the potential for large-scale pro-
duction of neuroblasts, confluent monolayers of passage-5 prolif-
erating cells (n  9, 80,000 cells per cm2) were differentiated as
described above, yielding 39,545	 2,691 neuroblasts (III tubulin
cells) per cm2 4 d after differentiation. These cells are stably
maintained in colonies on underlying glia and were easily isolatable
for subculture by detachment from underlying cells. Clonally plated
cells generated neuroblasts, albeit far less efficiently than did
adherent monolayers. Proliferating monolayers also generated
CNPaseO4 oligodendrocytes (data not shown). To examine the
feasibility of developing glial-derived neuroblasts into mature cell
types, we induced terminal differentiation using retinoic acid and
longitudinally monitored isolated colonies of newborn cells. After
their generation, immature A2B5nestinIII tubulin neuro-
blasts (Fig. 2a) lose nestin antigens and begin to extend bipolar
processes (Fig. 2b). With time, A2B5 expression is successively
Fig. 2. SVZ-generated neuroblasts develop into interneuron phenotypes. (a)
Upon appearance, neuroblasts coexpress nestin and III tubulin. (b) Soon
afterward, nestin expression is lost, and bipolar processes are extended. (c)
Expression of more mature neuronal markers corresponds to increasingly
complex neuronal arborization. At 28 d, abundant interneuron phenotypes
resemble granule-cell (d) and periglomerular (e) morphologies, expressing
GAD 6567. [Scale bars (in m): a–c, 25; d and e, 30.] The number of days
indicates time after the induction of differentiation.
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down-regulated, neuritic arborization becomes increasingly com-
plex, and more mature neuron markers are expressed (Fig. 2c;
NeuN not shown). At 3–4 weeks after growth-factor withdrawal,
characteristic mature interneuronal phenotypes are observed (Fig.
2 d and e). These neurons almost exclusively express GAD 6567,
a marker for GABAergic interneurons (Fig. 2e). Taken together,
these results suggest that it is possible to recapitulate and longitu-
dinally track a heteromorphic differentiation process in vitro that
temporally and phenotypically follows SVZ neurogenesis in vivo.
Real-time microscopy was used to capture and characterize the
immediate dynamics of localized neurogenic events (Fig. 3a). After
inducing differentiation, cells maintain a flat, amorphous-glial
appearance for 1 d. After this 24-h ‘‘silent’’ period, a sudden,
widespread series of rapid cell divisions leads to the initial appear-
ance of neuroblasts. The observed rapid proliferation during this
period appears to confirm the12.7-h cell-cycle time reported for
the transit-amplifying SVZ population in vivo (12). The timing of
appreciated mitotic activity is consistent with in vivo observations,
where50% of putative stem cells are mitotically active 48 h after
depleting constitutively proliferating SVZ cells (22). Similar to in
vivo studies (2), thymidine analog labeling with BrdUrd indicates
that themajority of neuroblasts are born 48–72 h after the induction
of differentiation (Fig. 3b). Our observations of immediate neuro-
genic events also correlated with the ability of differentiating cells
to form clonally derived, multipotent NS (Fig. 3c). Adherent cells
were trypsinized during proliferation, after 24 and 96 h of growth-
factor withdrawal, counted, and plated at clonal density in a
conventional NS-forming assay (see Materials and Methods). In
accordance with findings of decreased neurogenesis in adult brain
(23), the total numbers (and diameters) of NS formed in this assay
varied with the age of the SVZ tissue. However, a significant and
comparably transient increase of the frequency of NS-forming cells
was observed regardless of donor brain age at 24 h after induced
differentiation (1.86 and 1.6 times in P8- and adult-derived SVZ
cultures, respectively). For both age groups, dissociated primaryNS
yielded clonally derived, multipotent secondary NS (Fig. 3 d and e),
additionally demonstrating the self-renewing potential of rapidly
amplifying cells in our culture system.
Whole-cell patch-clamp recordings were used to monitor the
longitudinal transition of proliferating SVZ glial cells into mature
neuronal phenotypes in vitro. Proliferating cells (Fig. 4a) displayed
a predominance of A-type K currents (IKA) with hyperpolarized
resting membrane potentials. At 1 d after the induction of differ-
entiation, rapidly amplifying cells exhibit low potassium conduc-
tances and a predominance of delayed-rectifying K currents
(IKdr). At 4 d after induction, membrane properties of clustered
newborn cells resemble those of SVZ-born neuroblasts character-
ized in vivo in ref. 24. Neuroblasts present characteristic IKdr, with
no significant sodium-channel contribution. Significant changes in
passive membrane properties accompany the dramatic morpholog-
ical transition observed during the first 4 d of differentiation (Fig.
4b). After the initial period of rapid change, a second, protracted
Fig. 3. A mitotically active, multipotent cell emerges transiently during early stages of in vitro neuropoiesis. (a) Time-lapse microscopy of growth-factor-
withdrawn SVZ cultures reveals a transient period, characterized by rapid cell divisions, leading to the initial appearance of neuroblasts within 27 h. (b) BrdUrd
applied at 48–72 h after the initiation of differentiation labels 95% of all generated neuroblasts. (c) Clonal NS were derived from cultured P8 and adult SVZ
cells (Left for morphological comparison). Total numbers and relative frequencies (Right) of NS generated from 100,000 cells per condition increase significantly
but transiently at 24 h after growth-factor withdrawal (WD) (*, P 0.01 for adult and P8 compared with non-WD and 4-d WD). (d and e) Primary and secondary
P8 and adult (shown here) neurospheres yield neurons (d) and glia (e). [Scale bars (in m): a, 15; b, 60; c, 200; d and e, 20.]
9356  www.pnas.orgcgidoi10.1073pnas.0503965102 Scheffler et al.
period of functional neuronal maturation is entered that mimics
SVZ neurogenesis in vivo (8, 9). This includes gradual repolariza-
tion, an increasing membrane capacitance, and a slowly decreasing
membrane resistance (Fig. 4b). Similar to both in vitro (25) and in
vivo (8) recordings, immature neurons display tetraethylammonium
chloride (TEA)-sensitive IKdr at 9 	 2 d after induction (Fig. 4c).
In some bipolar cells, the application of TEA exposed underlying
IKA, a typical potassium current of proliferating immatureglial
cells (Fig. 4 a and c). Mature glial-derived neurons (28	 4 d) could
be elicited to fire series of tetrodotoxin-sensitive action potentials
(Fig. 4d). Surprisingly, spontaneous synaptic activity consisted
almost exclusively of inhibitory events (six of six recorded cells), as
demonstrated by the application of picrotoxin, an inhibitor of
GABA-mediated synaptic transmission (Fig. 4d). This finding
suggests that, similar to SVZ neurogenesis in vivo, the fate choice
of glial-derived neurons in vitro is largely restricted to inhibitory
phenotypes.
Discussion
The observations presented here expand our and others’ previous
in vitro studies that describe how stem-cell-derived neurons develop
basic biophysical characteristics (17, 26–28). Now, we can longitu-
dinally track, in vitro, the birth andmaturation of precursors specific
to the postnataladult SVZ, observing the similar timing of devel-
opmental events and lineage restrictions as they occur in vivo.
Moreover, our model offers the advantage of inducible neurogen-
esis, thereby generating populations of synchronously differentiat-
ing SVZ stem cells, which are in monolayers readily available for
single-cell analysis in real time throughout early and protracted
stages of differentiation. The use of this culture system also enabled
us to focus onpreviously uncharacterized events during the first 96 h
of SVZ stem-cell development. GFAPlowA2B5nestinIII
tubulinDlx-2PSA-NCAM proliferating glial cells develop
within 24 h into amultipotent, transit-amplifying GFAPA2B5
nestinIII tubulinDlx-2/PSA-NCAM population that
Fig. 4. Differentiating cells recapitulate membrane development consistent with a glial-to-neuron transition. (a) Proliferating (n  45), rapidly dividing (n 
8), and newborn neuroblast (n  20) cell populations were identified in culture by using infrared differential interference contrast microscopy. Patch-clamp
studies (voltage clamp,Center; current clamp,Right) reveal characteristic changes of functional phenotypes. Cells were incapable of generating action potentials
during this period. A small portion (6 of 45) of proliferating cells possessed tetrodotoxin (TTX)-sensitive voltage-gated sodium channels. (b) Passive membrane
properties (membrane potential, Vm; capacitance, Cm; and input resistance, Rm) during development of SVZ glial cells into functionally mature neuronal
phenotypes. (c) Voltage-clamp characterization of IKdr 9 d after growth-factor withdrawal (n  20). In some cells (cell 1), tetraethylammonium chloride
application exposes underlying IKA. (d) Mature interneurons at 28 days. Glial-derived mature neurons (n 14) fire TTX-sensitive action potentials. Spontaneous
synaptic activity can be recorded and entirely blocked by the application of picrotoxin (lower traces). prolif, proliferating; 1 day, rapidly dividing; 4 day,
neuroblast.
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gives rise to GFAPA2B5nestinIII tubulinDlx-2PSA-
NCAM precursors specific to the SVZ. We present a compre-
hensive electrophysiological characterization of the glial-to-neuron
transition of types B, C, and A cells that closely resembles their
transition in vivo (7). Significant changes of biophysical properties
parallel stage-specific morphological and ultrastructural character-
istics of differentiating cells. After induced differentiation, mor-
phologically unique A2B5 cells seem to first lose GFAP, and then
nestin, before converting into functionally mature A2B5
GABAergic interneurons. Thus, the A2B5 antigen, a developmen-
tally regulated tetrasialoganglioside (29), appears to denote the
sequential differentiation of a neural stemprogenitor cell en route
to becoming an interneuron. Furthermore, we propose that a
subpopulation ofA2B5 cells that coexpresses nestin and low levels
of GFAP could represent the founders for the SVZ-specific gen-
eration of interneurons. Even though the monoclonal antibody
A2B5 is not cell-type-specific, because it detects different precursor
cells in a variety of developing and adult CNS structures (30–34),
we found it intriguing that this antigen is also expressed by a
subpopulation of radial glial cells in the lateral ganglionic eminence
(LGE) between embryonic days 13.5 and 15.5 (35). The LGE
supplies interneurons to the olfactory bulb during brain develop-
ment (36) and is an ancestor of the postnataladult striatal SVZ. In
separate pilot studies, we performed immunolabeling on sections of
postnatal rat and mouse forebrain (data not shown) and found
A2B5 cells spatially restricted in the dorsolateral (striatal) aspect
of the lateral ventricles; this finding could explain, in part, the origin
of postnatal interneuron genesis, as we have now completely
recapitulated in vitro. The use of reductionist culture models
remains crucial for uncovering functional aspects of neural and
nonneural stem-cell biology (17, 37, 38). Yet, recent studies have
indicated that growth factors can significantly change the transcrip-
tional profile of neural precursor cells (39, 40). It is, therefore, a
major concern that cellular ‘‘reprogramming’’ induced by EGF,
FGF, serum, or other factors influences the behaviors of isolated
cells in culture. Of course, cells in vitro might not always behave
exactly as do their in vivo counterparts; however, we demonstrate
here that, despite disrupting a system that is clearly based on a large
degree of intercellular communication, all characteristic neuro-
genic events unique to the rodent subventricular zone can be
recapitulated in dissociated tissue culture. It can, therefore, be
concluded that ‘‘organotypic’’ postnatal neurogenesis does not
necessarily require the environmental cues of the host brain.
Alternatively, and on a broader perspective, the pioneering work of
Dexter et al. (41) showed how cells from bone marrow establish
themselves in adhesive culture conditions that mimic specific en-
vironmental cues for the proliferation and differentiation of hema-
topoietic cells. Our model could, hence, provide all essential
supplies of the environmental niche in the postnatal SVZ, and the
results presented here would further support our originally touted
similarities between hematopoiesis and neuropoiesis (42).
Uncovering the precisemorphogenic cadence during early stages
of neuropoiesis, including transitional states and sequential differ-
entiation, as shown here, thus provides insights into, as well as a
protocol for, targeted isolation and generation of distinct popula-
tions from the spectrum of stem cells to fully differentiated neurons
and glia in the adult brain. The SVZ, in vivo and in vitro, obviously
has a propensity to generate GABAergic interneurons. Such a fate
restriction associated with the known establishment of a forebrain
adult neuronal lineage challenges future research aimed at manip-
ulating neuropoiesis for desired neuronogenesis.
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